Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Genzyme Thyroid Cancer Drug Gets Broader U.S. Use
Link ID 1700
Title Genzyme Thyroid Cancer Drug Gets Broader U.S. Use
Url http://www.medscape.com/viewarticle/567610?src=rss
Description Genzyme Corp on Monday said the U.S. Food and Drug Administration approved a broader use of thyroid cancer treatment Thyrogen. The new indication will extend use of the drug to patients earlier in their treatment, the Cambridge, Massachusetts-based biotech said. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date Dec 19, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Surviving Survival Analysis: Why Censoring Is No Bad Thing
  What do statisticians mean when they use the term "mature"?
Medscape Business of Medicine
Category:   Articles > Business of Medicine


2. Do U.S. Pandemic Plans Threaten Rights, ACLU Asks
  U.S. policy in preparing for a potential bird flu pandemic is veering dangerously toward a heavy-handed law-enforcement approach, the American Civil Liberties Union said on Monday. Reuters Health Information
Category:   Articles > Business of Medicine


3. US FDA Staff Sees Risks With Investigational Psoriasis Drug
  An experimental psoriasis drug from Johnson & Johnson was effective in clinical trials, but long-term use may increase the risk of cancer, U.S. drug reviewers said in documents released on Friday. Reuters Health Information
Category:   Articles > Business of Medicine


4. Regional Anesthesia, Compression, and Aspirin Is the Safest Form of Prophylaxis for Hip and Knee Art
  Regional anesthesia, compression, and aspirin is the safest form of prophylaxis for hip and knee arthroplasty.
The Medscape Journal of Medicine
Category:   Articles > Business of Medicine


5. UnitedHealth Affirms Forecast Ahead of Investor Day
  UnitedHealth Group Inc said on Monday it plans to affirm its 2007 earnings forecast of $3.49 to $3.50 per share in conjunction with its investor conference on Tuesday. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS